Clinical Characteristics and Severity of Respiratory Syncytial Virus Infection in Korean Children during the Post-COVID-19 Pandemic Period
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We aimed to evaluate the clinical features of respiratory syncytial virus (RSV) infection and risk factors for severe RSV disease among Korean children in 2022/2023. A total of 235 children were identified, and 84.3% were hospitalized. Patients under 3 months and 2 years of age accounted for 20.9% and 54.5%, respectively. Pneumonia was diagnosed in 40.9% of children and bronchiolitis in 23.8%. Respiratory support and intensive care were required in 43.4% and 7.7% of patients, respectively. Haemophilus influenzae nasopharyngeal colonization and the presence of underlying disease showed a significant correlation with severity indicators. The clinical impact of RSV infection was high on infants and toddlers, even those having no underlying disease or not being indicated for palivizumab.
Abstract
We aimed to evaluate the clinical features of respiratory syncytial virus (RSV) infection and risk factors for severe RSV disease among Korean children in 2022/2023. A total of 235 children were identified, and 84.3% were hospitalized. Patients under 3 months and 2 years of age accounted for 20.9% and 54.5%, respectively. Pneumonia was diagnosed in 40.9% of children and bronchiolitis in 23.8%. Respiratory support and intensive care were required in 43.4% and 7.7% of patients, respectively. Haemophilus influenzae nasopharyngeal colonization and the presence of underlying disease showed a significant correlation with severity indicators. The clinical impact of RSV infection was high on infants and toddlers, even those having no underlying disease or not being indicated for palivizumab.
참고문헌 (13)
- Shi T, "Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015 : a systematic review and modelling study", Lancet, 390, pp.946~958 (2017)
- Hall CB, "The burden of respiratory syncytial virus infection in young children", N Engl J Med, 360, pp.588~598 (2009)
- Procedure for assessing the acceptability, in principle, of vaccines for purchase by United Nations agencies, "World Health Organization(WHO)", WHO, ~ (2006)
- Kim HW, "Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine", Am J Epidemiol, 89, pp.422~434 (1969)
- Kim HY, "Respiratory syncytial virus infection and the need for immunization in Korea", Expert Rev Vaccines, 22, pp.327~340 (2023)
- Mazur NI, "Respiratory syncytial virus prevention within reach : the vaccine and monoclonal antibody landscape", Lancet Infect Dis, 23, pp.e2~e21 (2023)
- Kampmann B, "Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants", N Engl J Med, 388, pp.1451~1464 (2023)
- Walsh EE, "Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults", N Engl J Med, 388, pp.1465~1477 (2023)
- Kim YK, "Shift in clinical epidemiology of human parainfluenza virus type 3 and respiratory syncytial virus B infections in Korean children before and during the COVID-19 pandemic : a multicenter retrospective study", J Korean Med Sci, 37, pp.e215~ (2022)
- Huh K, "Impact of nonpharmaceutical interventions on the incidence of respiratory infections during the coronavirus disease 2019(COVID-19)outbreak in Korea : a nationwide surveillance study", Clin Infect Dis, 72, pp.e184~e191 (2021)
- Hammitt LL, "Nirsevimab for prevention of RSV in healthy late-preterm and term infants", N Engl J Med, 386, pp.837~846 (2022)
- Chow EJ, "The effects of the COVID-19 pandemic on community respiratory virus activity", Nat Rev Microbiol, 21, pp.195~210 (2023)
- Choi SH, "Clinical characteristics and outcomes of children with SARS-CoV-2 infection during the delta and omicron variant-dominant periods in Korea", J Korean Med Sci, 38, pp.e65~ (2023)